New research from Pioneer Group, in collaboration with Beauhurst, reveals [...]

Centauri aims to start first-in-human clinical study for broad-spectrum immunotherapy [...]

Gesynta Pharma has announced the second closing of its Series [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]

Funding to advance EO2463 through Phase 1/2 and prepare for [...]

As global pharma grapples with shifting regulations, rising geopolitical tensions, [...]

Biostate AI has raised $12 million in Series A funding [...]

PhaseV has secured $50 million in Series A funding to [...]